The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00432-012-1300-5PMID 22926554PMCID PMC11824469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAR&bgr;2 gene methylation level in the circulating DNA from blood of patients with lung cancer

  2011cited by this paper
• Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer

  2011influential reference
• The blood nucleome in the pathogenesis of SLE.

  2010cited by this paper
• Molecular and Cellular Pathobiology Cancer Research Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells

  2010cited by this paper
• Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

  2009cited by this paper
• Profile of the circulating DNA in apparently healthy individuals.

  2009cited by this paper
• Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats.

  2008cited by this paper
• Overview of Circulating Nucleic Acids in Plasma/Serum

  2008cited by this paper
• Circulating Cell-Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring

  2008cited by this paper
• Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy

  2007cited by this paper
• Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma

  2007cited by this paper
• Free circulating DNA as possible tumour marker in colorectal cancer.

  2007cited by this paper
• SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

  2006cited by this paper
• Quantitative Analysis of Plasma DNA in Colorectal Cancer Patients

  2006cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells

  2005cited by this paper
• The predictive value of CD8, CD4, CD68, and human leukocyte antigen‐D‐related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase

  2005cited by this paper
• Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias

  2005cited by this paper
• Intratumoral CD8+ T Lymphocytes as a Prognostic Factor of Survival in Endometrial Carcinoma

  2004cited by this paper
• Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

  2004influential reference
• Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

  2004cited by this paper
• Detecting lung cancer in plasma with the use of multiple genetic markers

  2004cited by this paper
• Quantification of free circulating DNA as a diagnostic marker in lung cancer.

  2003cited by this paper
• Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells.

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• The function of the protein tyrosine phosphatase SHP-1 in cancer.

  2003cited by this paper
• Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

  2002cited by this paper
• Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.

  2002cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

  2001cited by this paper
• Bisulfite genomic sequencing: systematic investigation of critical experimental parameters

  2001cited by this paper
• Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.

  2000cited by this paper
• Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

  1999cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper
• Quantitative analysis

  year unknowncited by this paper

• The paradoxical prognostic effects of T-cell-derived circulating DNA in EGFR-mutated advanced non-small-cell lung cancer involve the crosstalk between heme biosynthesis and immune microenvironment

  2025cites this paper
• Presence of liver metastasis correlated with high tumor abundance and indicated adverse prognostic feature in EGFR mutation non-small-cell lung cancer patients

  2025cites this paper
• Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses

  2024cites this paper
• Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants

  2024cites this paper
• The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer

  2022cites this paper
• Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer

  2019cites this paper
• The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer

  2018cites this paper
• Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis

  2018cites this paper
• Comparison of 4 commercial kits for the extraction of circulating DNA from plasma.

  2018cites this paper
• Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

  2017cites this paper
• Comprehensive evaluation of extracellular small RNA isolation methods from serum in high throughput sequencing

  2017cites this paper
• Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

  2017cites this paper
• Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer

  2017cites this paper
• Quantitative Analysis of Circulating Cell‐Free DNA for Correlation with Lung Cancer Survival: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer

  2017cites this paper
• Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer

  2016cites this paper
• Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.

  2016cites this paper
• Circulating DNA and Survival in Solid Tumors

  2015cites this paper
• Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

  2015cites this paper
• Analysis of methylation microarray for tissue specific detection.

  2014cites this paper
• Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer

  2014cites this paper
• Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients

  2013cites this paper
• Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats

  2013cites this paper